CVS CVS Health Corp

$79.87

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

CVS Health's upcoming earnings report on October 29th is poised to capture attention, particularly as the company navigates the evolving healthcare landscape with a market cap of over $104 billion. Analysts are closely watching CVS's performance, especially given the EPS estimate of $1.37 and a revenue forecast of $98.87 billion. The whisper number, however, suggests a more optimistic EPS of $1.57, indicating that market insiders may expect stronger-than-anticipated results. This optimism could be fueled by CVS's strategic initiatives in expanding its healthcare services and digital health solutions, which have been pivotal in driving growth and enhancing customer engagement. As CVS continues to integrate its pharmacy and health services, investors will be keen to see how these efforts translate into financial performance, particularly in light of the competitive pressures within the healthcare sector. The upcoming earnings release will thus be a critical indicator of CVS Health's ability to sustain its growth trajectory and meet or exceed market expectations.

Updated On 12/31/2025

About CVS Health Corp

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Website: https://www.cvshealth.com

Sector
TRADE & SERVICES
Industry
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
64803
Address
ONE CVS DR., WOONSOCKET, RI, US
Valuation
Market Cap
$84.95B
P/E Ratio
18.39
PEG Ratio
0.70
Price to Book
1.12
Performance
EPS
$3.66
Dividend Yield
3.95%
Profit Margin
1.25%
ROE
6.02%
Technicals
50D MA
$65.40
200D MA
$58.69
52W High
$71.45
52W Low
$43.01
Fundamentals
Shares Outstanding
1B
Target Price
$75.97
Beta
0.57

CVS EPS Estimates vs Actual

Estimated
Actual

CVS News & Sentiment

Dec 30, 2025 • Finviz SOMEWHAT-BULLISH
Why Did Molina Healthcare Stock Surge Today?
Molina Healthcare stock surged nearly 5% today after famed investor Michael Burry publicly highlighted his investment in the company, calling it a potential "generational buy." Burry, known for "The Big Short," revealed he has been long on Molina since November and reiterated his positive outlook, drawing investor attention. This surge comes despite the stock being down 40% year-to-date, prompting some to consider Molina Healthcare as a potential acquisition target.
Dec 30, 2025 • Benzinga NEUTRAL
Peering Into CVS Health Corp's Recent Short Interest
CVS Health Corp (NYSE: CVS) has seen a 17.31% increase in its short interest as a percent of float, with 22.92 million shares currently sold short. This represents 1.83% of all available shares, and it would take traders 2.55 days to cover their positions. Despite this rise, CVS's short interest is lower than the average of its peers, which stands at 9.40%.
Dec 30, 2025 • Insider Monkey SOMEWHAT-BULLISH
CVS Gets Higher Target as Bernstein Cites Management Confidence
Bernstein raised its price target for CVS Health Corporation to $87 from $86, maintaining a Market Perform rating, following a "very positive" Investor Day. The firm cited increased confidence in CVS's management and market leadership. This comes after CVS increased its 2025 profit forecast and introduced a new consumer app, with the company forecasting at least $400 billion in total revenue for 2026.
Dec 30, 2025 • NJ.com NEUTRAL
What stores are open on New Year’s Eve 2025? Costco hours, Walmart hours, Aldi hours, ShopRite Liquors hours
This article provides a comprehensive guide to store and mall hours on New Year's Eve 2025, noting that most will be open with reduced hours. It lists specific operating times for numerous grocery stores, major retailers, and shopping malls, primarily focusing on New Jersey locations. Shoppers are advised to check with their local stores for exact hours, as they may vary.
Dec 30, 2025 • Finviz SOMEWHAT-BULLISH
Where is CVS Health Corporation (CVS) Headed According to Analysts?
CVS Health Corporation (CVS) has received positive analyst ratings from RBC Capital and JPMorgan, with price target increases and maintained Buy/Overweight ratings. The company also updated its financial guidance, raising total revenues for 2025 to at least $400.0 billion and initiating strong 2026 guidance, anticipating mid-teens Adjusted EPS CAGR through 2028. Analysts see reasons for optimism in managed care estimates approaching trough levels.
Dec 30, 2025 • Insider Monkey SOMEWHAT-BULLISH
Where is CVS Health Corporation (CVS) Headed According to Analysts?
CVS Health Corporation (NYSE: CVS) received recent rating updates from RBC Capital and JPMorgan, maintaining Buy and Overweight ratings with price targets of $93.00 and $101, respectively. The company also updated its 2025 financial guidance, raising revenue and operating income forecasts, and initiated a robust 2026 outlook with expectations for mid-teens Adjusted EPS CAGR through 2028.
Sentiment Snapshot

Average Sentiment Score:

0.121
50 articles with scored sentiment

Overall Sentiment:

Neutral

CVS Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.35 Surprise
  • Reported EPS: $1.81
  • Estimate: $1.46
  • Whisper:
  • Surprise %: 24.0%
May 01, 2025
Mar 31, 2025 (Pre market)
0.58 Surprise
  • Reported EPS: $2.25
  • Estimate: $1.67
  • Whisper:
  • Surprise %: 34.7%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.27 Surprise
  • Reported EPS: $1.19
  • Estimate: $0.92
  • Whisper:
  • Surprise %: 29.4%
Nov 06, 2024
Sep 30, 2024 (Pre market)
-0.37 Surprise
  • Reported EPS: $1.09
  • Estimate: $1.46
  • Whisper:
  • Surprise %: -25.3%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.1 Surprise
  • Reported EPS: $1.83
  • Estimate: $1.73
  • Whisper:
  • Surprise %: 5.8%
May 01, 2024
Mar 31, 2024 (Pre market)
-0.39 Surprise
  • Reported EPS: $1.31
  • Estimate: $1.70
  • Whisper:
  • Surprise %: -22.9%
Feb 07, 2024
Dec 31, 2023 (Pre market)
0.13 Surprise
  • Reported EPS: $2.12
  • Estimate: $1.99
  • Whisper:
  • Surprise %: 6.5%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.08 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.13
  • Whisper:
  • Surprise %: 3.8%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.11
  • Whisper:
  • Surprise %: 4.7%

Financials